Key result
Therapeutic hypothermia improves favorable neurological outcomes at discharge by ~40% across RCTs.
Why the study?
Cardiac arrest is associated with poor neurological outcomes, and the neuroprotective role of therapeutic hypothermia remains controversial.
Does therapeutic hypothermia (32-34 °C) improve favorable neurological outcomes at hospital discharge compared with controlled normothermia (36-38 °C) in adult patients after cardiac arrest?
Meta-Analysis (n=33,696)
Does therapeutic hypothermia (32-34 °C) improve favorable neurological outcomes at hospital discharge compared with controlled normothermia (36-38 °C) in adult patients after cardiac arrest?
Although therapeutic hypothermia (32-34 °C) was associated with improved neurological outcomes at hospital discharge and a borderline reduction in hospital mortality compared with controlled normothermia after adult cardiac arrest, trial sequential analysis reveals that current randomized evidence is underpowered to confirm a definitive benefit, and no difference was seen at 180 days.
Answers are grounded in this paper and cite their sources.
May enhance short-term neurological outcomes after cardiac arrest; leaves open definitive benefit as evidence remains underpowered.
Background:Cardiac arrest (CA) is associated with poor neurological outcomes.The neuroprotective role of therapeutic hypothermia (TH) remains controversial.We hypothesized that TH would be associated with a higher likelihood of favorable neurological outcome at hospital discharge. Material/Methods:PubMed, Embase, and the Cochrane Library were searched through August 2025.Randomized controlled trials (RCTs) and cohort studies comparing hypothermia (32-34 °C) with controlled normothermia (36-38 °C) were included.The primary outcome was favorable neurological outcome at hospital discharge, defined as a Cerebral Performance Category (CPC) score of 1-2 or a modified Rankin Scale (mRS) score of 0-3.Secondary outcomes were favorable neurological outcome at 180-day follow-up, hospital mortality, and adverse events.Pooled estimates were calculated using the Mantel-Haenszel method, with fixed-or random-effects models applied according to heterogeneity, with pre-specified subgroup analyses.Trial sequential analysis (TSA) was performed for the primary outcome to assess the robustness of the pooled estimates. Results:Ten RCTs and 19 cohort studies involving 33 696 patients were included.In RCTs, TH was associated with a higher likelihood of favorable neurological outcome at hospital discharge (RR = 1.40; 95% CI, 1.10-1.77;I 2 = 47%).No significant improvement was observed in neurological outcomes at 180-day follow-up.A small borderline reduction in hospital mortality was observed in the hypothermia group (RR = 0.9268; 95% CI, 0.8620-0.9963;P = 0.04).TSA indicated insufficient randomized evidence.TH was associated with more arrhythmia, while other adverse events were similar.Subgroup analyses showed no significant interaction by initial rhythm.Observational studies suggested better neurological outcomes and lower mortality with TH but showed substantial heterogeneity.Conclusions:TH may be associated with better neurological outcomes at hospital discharge after CA, but TSA indicated that the current randomized evidence remains insufficient to confirm a definitive benefit.No significant improvement was observed in neurological outcomes at 180-day follow-up.A small borderline reduction in hospital mortality was observed, while no demonstrated subgroup interaction was identified by initial rhythm.Further adequately powered RCTs are needed to clarify patient selection and optimize hypothermic temperature control strategies.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2026) conducted a meta-analysis in Adult cardiac arrest with return of spontaneous circulation (ROSC) (n=33,696). Therapeutic hypothermia (hypothermic temperature control) vs. Controlled normothermia (active temperature control at 36-38 °C, including fever prevention) was evaluated on Favorable neurological outcome at hospital discharge in RCTs, defined as Cerebral Performance Category (CPC) score 1-2 or modified Rankin Scale (mRS) score 0-3 (RR 1.40, 95% CI 1.10-1.77, p=0.005). Therapeutic hypothermia increased favorable neurological outcomes at hospital discharge in RCTs, though trial sequential analysis showed insufficient evidence.
Synapse has enriched 10 related papers. Consider them for comparative context: